Synairgen PLC Registered Shares LS -,01

WKN A0DK7J ISIN GB00B0381Z20

Quote/Chart

  • Bid

    0.07

    1,100 Units

  • Ask

    0.083

    1,100 Units

  • Change compared with previous day (price)

    +0.00 / +0.72 %

  • Spread (Act/ Rel)

    0.013 / 18.571 %

  • Today's high (Price)

    0.07

  • Today's low (Price)

    0.0695

Facts & figures

Price data

Trade platform Börse Stuttgart (XSTU)  
Last price 0.07 G 0 Units
Price determination time 04/29/2024 / 03:18:53 PM
Daily volume (units) 0
Daily high / low 0.07 0.0695
Prev. day's price 0.0695 (26.04.)
Change day before +0.00 0.72 %
52 week high / low 0.136 (27/04) 0.0325 (01/03)

Key Figures (in EUR)

2023 2022 2021
Earnings per share - -0.10 -0.28
Dividends per share - 0.00 0.00
Dividend Yield in % - 0.00% 0.00%
Dividend growth in % - - -
Price - Earnings ratio - - -
Price - Book ratio - 1.34 11.32
Price - Sales ratio - - -
Price - Cash Flow Ratio - - -

Master Data

WKN
A0DK7J
ISIN
GB00B0381Z20
Symbol
OMY
Exchange segment
Open Market
Type of financial instrument
Equity
Denomination
SYNAIRGEN PLC LS-,01
Index membership
-
Trading segment
-
Trading hours
08:00:00 - 22:00:00
Trading currency
Euro
Nominal currency
-
Settlement currency
Euro
Sector and industry
Chemical/Pharmaceutical/Health, Pharmaceuticals
Number of shares
-
Market capitalisation
-

Performance overview

1W 1M 3M 6M 1Y 3Y 5Y YTD
Performance -0.71% 33.91% 8.93% 1.91% -49.05% -95.89% -48.52% 7.09%
High 0.08 0.11 0.11 0.11 0.14 2.50 2.86 0.11
Low 0.07 0.05 0.03 0.03 0.03 0.03 0.03 0.03

Company profile

Synairgen Plc is a holding company, which engages in the provision of respiratory drug discovery and development. It focuses on severe asthma, chronic obstructive pulmonary disease, and severe viral infections. The company was founded by Donna E. Davies, Ratko Djukanovic, and Stephen T. Holgate in June 2003 and is headquartered in Southampton, the United Kingdom.